"Patients with psoriatic arthritis (PsA) may be at increased risk for experiencing significant cardiovascular (CV) events, a new study suggests.
"[T]hese findings support the notion that PsA should be considered as an independent risk "...
(Generic versions may still be available.)
DOSAGE AND ADMINISTRATION
The usual dosage is 3000 mg daily, given in divided doses as follows: 1) two doses of two 750 mg tablets: 2) two doses of three 500 mg tablets/capsules; or 3) three doses of two 500 mg tablets/capsules. Some patients, e.g., the elderly, may require a lower dosage to achieve therapeutic blood concentrations and to avoid the more common side effects such as auditory.
Alleviation of symptoms is gradual, and full benefit may not be evident for 3 to 4 days, when plasma salicylate levels have achieved steady state. There is no evidence for development of tissue tolerance (tachyphylaxis) but salicylate therapy may induce increased activity of metabolizing liver enzymes, causing a greater rate of salicyluric acid production and excretion, with a resultant increase in dosage requirement for maintenance of therapeutic serum salicylate levels.
Dosage recommendations and indications for DISALCID (salsalate) use in children have not been established.
Bottles of 100 (NDC #0089-0148-10)
Each DISALCID (salsalate) 500 mg aqua, film coated, round, bisected tablet embossed with DISALCID (salsalate) on one side and 3M on the other side is available in:
Bottles of 100 (NDC #0089-0149-10)
Bottles of 500 (NDC #0089-0149-50)
Each DISALCID (salsalate) 750 mg aqua, film coated, capsule shaped, bisected tablet embossed with DISALCID (salsalate) 750 on one side and 3M on the other side is available in:
Bottles of 100 (NDC #0089-0151-10)
Bottles of 500 (NDC #0089-0151-50)
Store at controlled room temperature 15°-30°C (59°-86°F).
Northridge, CA 91324
Last reviewed on RxList: 12/8/2004
Additional Disalcid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options